Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12969-020-00422-z http://scihub22266oqcxt.onion/10.1186/s12969-020-00422-z 32321540!7175817!32321540     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Rheumatol+Online+J 2020 ; 18 (1): 35 Nephropedia Template TP {{tp|p=32321540|t=2020. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country |pdf=|usr=}}{{32321540}} gab.com Text COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country JO: Pediatr Rheumatol Online J http://www.kidney.de/pget.php?&tw=1&pmid=32321540 #FOAvip On March 11th, 2020 the World Health Organization declared COVID-19 a global pandemic. The infection, transmitted by 2019 novel coronavirus (2019-nCov), was first discovered in December 2019, in Wuhan, Hubei Province, and then rapidly spread worldwide. Italy was early and severely involved, with a critical spread of the infection and a very high number of victims. Person-to-person spread mainly occurs via respiratory droplets and contact. The median incubation period is 5 days. The spectrum of respiratory symptoms may range from mild to severe, strictly depending on the age of the patient and the underlying comorbidities.In children COVID-19 related disease is less frequent and less aggressive. In Italy 1% of positive cases are under 18 years of age, and no deaths have been recorded before 29 years of age. For patients affected by rheumatic disease, despite the concerns related to the imbalance of their immune response and the effect of immunosuppressive treatments, there are still few data to understand the real consequences of this infection. Major scientific societies have issued recommendations to help rheumatologists in caring their patients. Interestingly, some of the drugs mostly used by rheumatologists appear to be promising in critical COVID-19 infected patients, where the hyperinflammation and cytokine storm seem to drive to the multiorgan failure.Pediatric rheumatologists are expected to play a supporting role in this new front of COVID-19 pandemic, both as general pediatricians treating infected children, and as rheumatologists taking care of their rheumatic patients, as well as offering their experience in the possible alternative use of immunomodulatory drugs. Twit Text FOAVip COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country ????Pediatr Rheumatol Online J http://www.kidney.de/pget.php?&tw=1&pmid=32321540 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32321540 #FOAvip English Wikipedia <ref>{{Cite pmid|32321540}}</ref> COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country #MMPMID32321540 Licciardi F; Giani T; Baldini L; Favalli EG; Caporali R; Cimaz R Pediatr Rheumatol Online J 2020[Apr]; 18 (1): 35 PMID32321540show ga On March 11th, 2020 the World Health Organization declared COVID-19 a global pandemic. The infection, transmitted by 2019 novel coronavirus (2019-nCov), was first discovered in December 2019, in Wuhan, Hubei Province, and then rapidly spread worldwide. Italy was early and severely involved, with a critical spread of the infection and a very high number of victims. Person-to-person spread mainly occurs via respiratory droplets and contact. The median incubation period is 5 days. The spectrum of respiratory symptoms may range from mild to severe, strictly depending on the age of the patient and the underlying comorbidities.In children COVID-19 related disease is less frequent and less aggressive. In Italy 1% of positive cases are under 18 years of age, and no deaths have been recorded before 29 years of age. For patients affected by rheumatic disease, despite the concerns related to the imbalance of their immune response and the effect of immunosuppressive treatments, there are still few data to understand the real consequences of this infection. Major scientific societies have issued recommendations to help rheumatologists in caring their patients. Interestingly, some of the drugs mostly used by rheumatologists appear to be promising in critical COVID-19 infected patients, where the hyperinflammation and cytokine storm seem to drive to the multiorgan failure.Pediatric rheumatologists are expected to play a supporting role in this new front of COVID-19 pandemic, both as general pediatricians treating infected children, and as rheumatologists taking care of their rheumatic patients, as well as offering their experience in the possible alternative use of immunomodulatory drugs. |*Pediatricians[MESH] |*Rheumatologists[MESH] |Adolescent[MESH] |Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use[MESH] |Antirheumatic Agents/*therapeutic use[MESH] |Arthritis, Juvenile/complications/virology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Child[MESH] |Child, Preschool[MESH] |Chloroquine/therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*complications/*drug therapy/epidemiology[MESH] |Cytokine Release Syndrome/drug therapy/virology[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Infant[MESH] |Interleukin-6/antagonists & inhibitors[MESH] |Italy/epidemiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/*drug therapy/epidemiology[MESH] |Rheumatic Diseases/*complications/*virology[MESH]COVID-19 and what pediatric rheumatologists should know: a review from(epmc).pdf DeepDyve Pubget Overpricing